Annual report pursuant to Section 13 and 15(d)


5 Months Ended
Dec. 31, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (16,296,019)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in fair value of warrant liability 15,007,134
Transaction costs allocated to warrant liabilities 1,152,775
Interest earned on marketable securities held in Trust Account (67,699)
Changes in operating assets and liabilities:  
Prepaid expenses (290,394)
Accrued expenses 109,103
Net cash used in operating activities (385,100)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (450,000,000)
Net cash used in investing activities (450,000,000)
Cash Flows from Financing Activities:  
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from sale of Units, net of underwriting discounts paid 441,000,000
Proceeds from sale of Private Placement Warrants 11,000,000
Proceeds from promissory note - related party 125,000
Repayment of promissory note - related party (125,000)
Payment of offering costs (552,024)
Net cash provided by financing activities 451,472,976
Net Change in Cash 1,087,876
Cash - Beginning of period 0
Cash - End of period 1,087,876
Non-Cash Financing Activities:  
Initial classification of Class A common stock subject to possible redemption 400,487,620
Change in value of Class A common stock subject to possible redemption (15,142,240)
Deferred underwriting fee payable 15,750,000
Offering costs included in accrued offering costs 16,480
Forfeiture of Founder Shares $ (25)